Respiratory impairment after completion of TB treatment: a neglected but vitally important issue
Int J Tuberc Lung Dis
.
2024 Sep 1;28(9):410-411.
doi: 10.5588/ijtld.24.0341.
Authors
L N Nguyen
1
,
P T Phan
2
,
E Jaramillo
1
,
A Dinh
3
,
A T Dinh-Xuan
4
Affiliations
1
Global Tuberculosis Programme, World Health Organization. Geneva, Switzerland.
2
Respiratory Department, Hue National General Hospital, Hue, Vietnam.
3
Infectious Disease Unit, Raymond-Poincaré University Hospital, Assistance Publique-Hôpitaux de Paris, Paris Saclay University, Garches, France.
4
Department of Respiratory Medicine and Physiology, Hôpital Cochin, Paris, France.
PMID:
39188002
DOI:
10.5588/ijtld.24.0341
No abstract available
Publication types
Editorial
MeSH terms
Antitubercular Agents* / administration & dosage
Humans
Tuberculosis / drug therapy
Tuberculosis, Pulmonary / drug therapy
Substances
Antitubercular Agents
Grants and funding
001/WHO_/World Health Organization/International